Rhythm Drops $86M IPO Plan After Actavis Deal
Rhythm Pharmaceuticals Inc. on Wednesday pulled its planned $86 million initial public offering after the company reached a deal last week with Actavis PLC for an exclusive option to purchase one...To view the full article, register now.
Already a subscriber? Click here to view full article